ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 160 filers reported holding ALLOGENE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.17 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $5,772,103 | +1.3% | 1,798,163 | 0.0% | 6.87% | -22.1% |
| Q3 2023 | $5,700,177 | -36.2% | 1,798,163 | 0.0% | 8.82% | -24.4% |
| Q2 2023 | $8,936,870 | +0.6% | 1,798,163 | 0.0% | 11.67% | -4.0% |
| Q1 2023 | $8,882,925 | -21.5% | 1,798,163 | 0.0% | 12.15% | -20.0% |
| Q4 2022 | $11,310,445 | -41.8% | 1,798,163 | 0.0% | 15.20% | -12.8% |
| Q3 2022 | $19,420,000 | -5.3% | 1,798,163 | 0.0% | 17.43% | +0.6% |
| Q2 2022 | $20,499,000 | +25.1% | 1,798,163 | 0.0% | 17.32% | +81.8% |
| Q1 2022 | $16,381,000 | -38.9% | 1,798,163 | 0.0% | 9.53% | -5.1% |
| Q4 2021 | $26,829,000 | -41.9% | 1,798,163 | 0.0% | 10.04% | -24.2% |
| Q3 2021 | $46,213,000 | -1.5% | 1,798,163 | 0.0% | 13.24% | +12.6% |
| Q2 2021 | $46,896,000 | -26.1% | 1,798,163 | 0.0% | 11.76% | -26.7% |
| Q1 2021 | $63,475,000 | +39.9% | 1,798,163 | 0.0% | 16.04% | +72.1% |
| Q4 2020 | $45,386,000 | -33.1% | 1,798,163 | 0.0% | 9.32% | -78.1% |
| Q3 2020 | $67,809,000 | – | 1,798,163 | – | 42.47% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VV Manager LLC | 1,798,163 | $76,997,000 | 67.53% |
| Wildcat Capital Management, LLC | 1,515,524 | $64,895,000 | 22.42% |
| TPG Group Holdings (SBS) Advisors, Inc. | 19,716,306 | $844,252,000 | 14.91% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 1,279,281 | $54,779,000 | 7.69% |
| Coastal Bridge Advisors, LLC | 463,117 | $19,831,000 | 6.33% |
| DSAM Partners (London) Ltd | 235,098 | $10,067,000 | 2.63% |
| Casdin Capital, LLC | 625,000 | $26,763,000 | 1.58% |
| Alpine Global Management, LLC | 150,000 | $6,423,000 | 1.13% |
| Perceptive Advisors | 1,543,790 | $66,105,000 | 1.07% |
| Avoro Capital Advisors LLC | 1,128,594 | $48,326,000 | 0.96% |